CD28 and graft versus host disease: Whereas aforementioned studies utilised Treg to prevent GVHD, Trzonkowski et al. [34•] have reported their findings from two patients with GVHD who were treated with anti-CD3/anti-CD28 bead expanded CD25+CD127lo Treg.